Document is current
Any future updates will be listed below
-
Authors
Cavaller-Bellaubi, Maria https://orcid.org/0000-0002-6658-6863
Degraeuwe, Eva https://orcid.org/0000-0003-2523-3022
Vande Walle, Johan https://orcid.org/0000-0001-9700-5358
Gasthuys, Elke https://orcid.org/0000-0002-0503-3560
Prytula, Agnieszka https://orcid.org/0000-0001-9551-8758
,
Allegaert, Karel
Bertolani, Arianna
Bonifazi, Donato
Boven, Katia
Breitenstein, Stephanie
Clark, Abby
Claverol, Joana
Corriol-Rohou, Solange
Crawley, Francis
de Bruyne, Ruth
de Groote, Katya
de Guchtenaere, Ann
de Lisa, Roberto
Dehlinger-Kremer, Martine
Egger, Gunter
Eygenraam, Margriet
Ferrer, Elisa
Furlong, Pat
Davies, Elin Haf
Jonker, Anneliene
Lepola, Pirkko
Lopez, Elisa
Mahler, Fenna
Mavris, Maria
Nafria, Begoña
Natale, Alessandra
Nuytinck, Lieve
Ollivier, Cécile
Preston, Jennifer
Raes, Ann
Scheeren, Joseph
Schmidt, Jeff
Schmidt-Goldstein, Sabina
Snauwaert, Evelien
Tan, Lionel
Tenningkeit, Frank
Turner, Mark
Van Meel, Marieke
Wyngaert, Karsten Vanden
Vlaeminck, Aline
Vroom, Elizabeth
West, Leanne
- License Information
-
More Information
Article History
Received: 11 September 2024
Accepted: 15 November 2024
First Online: 27 November 2024
Declarations
:
: Participants were invited to take part in the questionnaires and workshop, and their acceptance to participate constituted consent to be part of the study. This approach was deemed appropriate given the nature of the research and the minimal risks involved.
: Not applicable.
: MCB, ED, EG: no conflicts of interest. JVW consultancy Ferring, Astellas, Bayer, Alexion. AP- none pertaining to this publication; in the last 5 years research grant Sandoz and Novo Nordisk.
